Cytomegalovirus and Epstein–Barr virus co-infected young and middle-aged adults can have an aging-related T-cell phenotype
Marloes I. Hofstee, Alper Çevirgel, Mary‐lène de Zeeuw‐Brouwer, Lia de Rond, Fiona van der Klis, Anne‐Marie Buisman
Abstract
Abstract Cytomegalovirus (CMV) is known to alter circulating effector memory or re-expressing CD45RA + (TemRA) T-cell numbers, but whether Epstein–Barr virus (EBV) does the same or this is amplified during a CMV and EBV co-infection is unclear. Immune cell numbers in blood of children and young, middle-aged, and senior adults ( n = 336) were determined with flow cytometry, and additional multivariate linear regression, intra-group correlation, and cluster analyses were performed. Compared to non-infected controls, CMV-seropositive individuals from all age groups had more immune cell variance, and CMV + EBV − senior adults had more late-differentiated CD4 + and CD8 + TemRA and CD4 + effector memory T-cells. EBV-seropositive children and young adults had a more equal immune cell composition than non-infected controls, and CMV − EBV + senior adults had more intermediate/late-differentiated CD4 + TemRA and effector memory T-cells than non-infected controls. CMV and EBV co-infected young and middle-aged adults with an elevated BMI and anti-CMV antibody levels had a similar immune cell composition as senior adults, and CMV + EBV + middle-aged adults had more late-differentiated CD8 + TemRA, effector memory, and HLA-DR + CD38 − T-cells than CMV + EBV − controls. This study identified changes in T-cell numbers in CMV- or EBV-seropositive individuals and that some CMV and EBV co-infected young and middle-aged adults had an aging-related T-cell phenotype.